89 results
Page 2 of 5
8-K/A
EX-99.1
48gic
22 Nov 23
Report of Independent Auditors
4:02pm
8-K/A
EX-99.2
dn3aeejxgwq7hkv3 df2
22 Nov 23
Report of Independent Auditors
4:02pm
8-K/A
EX-99.3
was3eeut
22 Nov 23
Report of Independent Auditors
4:02pm
8-K
EX-99.1
o6vueq52i cgbkfav
9 Nov 23
Immunome Reports Third Quarter 2023 Financial Results
4:52pm
8-K
uv96 dj5gddfa7rs0m8
4 Oct 23
Immunome and Morphimmune Announce Successful Completion of Merger with $125 Million PIPE to Develop Novel Targeted Cancer Therapies
6:56am
424B3
rcsfu
28 Aug 23
Prospectus supplement
9:10am
S-4/A
mud4huxh3pm4tquicv
25 Aug 23
Registration of securities issued in business combination transactions (amended)
6:38am
8-K
EX-99.1
4u5abbyv k8vpehf
9 Aug 23
Immunome Reports Second Quarter 2023 Financial Results
8:27am
S-4
EX-10.42
t1qdax216du8a7aigf8i
8 Aug 23
Registration of securities issued in business combination transactions
4:07pm
S-4
EX-10.43
6hg dspm9w
8 Aug 23
Registration of securities issued in business combination transactions
4:07pm
S-4
cmt i7go409g2
8 Aug 23
Registration of securities issued in business combination transactions
4:07pm
8-K
EX-99.1
rkywqa1heiyyz7q
5 May 23
Immunome Reports First Quarter 2023 Financial Results
8:19am
PRE 14A
yk7d4
7 Apr 23
Preliminary proxy
6:29am
8-K
EX-99.1
mgepjvj fl
15 Nov 22
Other Events
4:17pm
8-K
EX-99.1
bbxl404vl894d
14 Nov 22
Immunome Reports Third Quarter 2022 Financial Results
9:06am